Bauya, Jaime S.

HRN: 28-69-76  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/17/2026
03/24/2026
IV
4.5g Loading Dose Then 2.5g
Q 8
UGIB With Leukocytosis
Checking Initial Appropriateness 
03/23/2026
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
03/23/2026
03/30/2026
TOPICAL
1%
BID
Decubitus Ulcers
Remove - Pending Acceptance
03/26/2026
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
03/26/2026
04/01/2026
TOPICAL
1%
BID
Sacral Decubitus Ulcer
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: